blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0981606

EP0981606 - METHOD AND CONSTRUCT FOR INHIBITION OF CELL MIGRATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.05.2006
Database last updated on 25.09.2024
Most recent event   Tooltip12.05.2006Application deemed to be withdrawnpublished on 14.06.2006  [2006/24]
Applicant(s)For all designated states
Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO
Anna van Buerenplein 1
2595 DA 's-Gravenhage / NL
[N/P]
Former [2000/09]For all designated states
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO
Schoemakerstraat 97, P.O. Box 60680
2628 VK Delft / NL
Inventor(s)01 / QUAX, Paulus, Hubertus, Andreas
Jacob van Heemskercklaan 59
NL-2253 JX Voorschoten / NL
02 / VERHEIJEN, Johan, Hendrikus
Verdistraat 14
NL-2651 VB Berkel en Rodenrijs / NL
[2000/09]
Representative(s)Prins, Adrianus Willem, et al
V.O.
Johan de Wittlaan 7
2517 JR Den Haag / NL
[N/P]
Former [2003/15]Prins, Adrianus Willem, et al
Vereenigde, Nieuwe Parklaan 97
2587 BN Den Haag / NL
Former [2000/09]Ottevangers, Sietse Ulbe, et al
Vereenigde Octrooibureaux Nieuwe Parklaan 97
2587 BN 's-Gravenhage / NL
Application number, filing date98923197.211.05.1998
[2000/09]
WO1998NL00259
Priority number, dateEP1997020142312.05.1997         Original published format: EP 97201423
[2000/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9851788
Date:19.11.1998
Language:EN
[1998/46]
Type: A2 Application without search report 
No.:EP0981606
Date:01.03.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 19.11.1998 takes the place of the publication of the European patent application.
[2000/09]
Search report(s)International search report - published on:EP20.05.1999
ClassificationIPC:C12N9/72, C12N15/62, C07K14/81
[2000/09]
CPC:
C12N9/6459 (EP); C07K14/485 (EP); C07K14/8114 (EP);
C07K14/8117 (EP); C07K14/8146 (EP); C12Y304/21069 (EP);
A61K38/00 (EP); C07K2319/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   IT,   LI,   LU,   NL,   SE [2000/09]
TitleGerman:VERFAHREN UND VEKTOR ZUR HEMMUNG DER ZELL-MIGRATION[2000/09]
English:METHOD AND CONSTRUCT FOR INHIBITION OF CELL MIGRATION[2000/09]
French:PROCEDE ET CONSTRUCTION POUVANT INHIBER UNE MIGRATION CELLULAIRE[2000/09]
Entry into regional phase22.10.1999National basic fee paid 
22.10.1999Designation fee(s) paid 
22.10.1999Examination fee paid 
Examination procedure11.12.1998Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.10.1999Examination requested  [2000/09]
02.12.2003Despatch of a communication from the examining division (Time limit: M06)
10.06.2004Reply to a communication from the examining division
23.05.2005Despatch of a communication from the examining division (Time limit: M06)
03.12.2005Application deemed to be withdrawn, date of legal effect  [2006/24]
11.01.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/24]
Fees paidRenewal fee
24.05.2000Renewal fee patent year 03
19.04.2001Renewal fee patent year 04
19.04.2002Renewal fee patent year 05
23.04.2003Renewal fee patent year 06
27.04.2004Renewal fee patent year 07
13.05.2005Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9634009  (RUTGERS THE STATE UNIVERSITY OF NEW JERSEY) [X] 1,13-15,18,19 * page 10, line 10 - page 20, line 2 *;
 [X]WO9112328  (FOWLKES DANA M ET AL) [X] 1 * the whole document, esp. page 1-2 and page 28, line 20 - page 39, line 26 *;
 [X]WO9623814  (CELL GENESYS INC) [X] 1,18 * page 9 - page 10 *;
 [X]EP0383599  (MERCK & CO INC) [X] 1-3,6,19 * the whole document *;
 [A]WO9528955  (GLIEMANN JOERGEN ET AL) [A] 1,3 * the whole document *;
 [A]WO9511987  (INCYTE PHARMA INC) [A] 1-5,7,18,19 * page 25, line 4 - page 27, line 13 * * page 85, line 10 - page 87, line 17 *;
 [DA]WO9202553  (DELTA BIOTECHNOLOGY LTD) [DA] 1-5,7,8,11,18 * page 3, line 10 - page 9, line 1 *;
 [XA]WO9517885  (RUTGERS , THE STATE UNIVERSITY OF NEW JERSEY) [X] 1,7,8 * page 7, line 7 - line 10 * * page 15, line 1 - page 23, line 36 * * page 32, line 1 - page 34, line 6 * [A] 2-5;
 [DPX]WO9725422  (NISSIN FOOD PRODUCTS LTD) [DPX] 1-5,7 * abstract *;
 [X]EP0439954  (SERAGEN INC) [X] 1,6 * page 1 - page 4 *;
 [X]WO9700949  (MASSACHUSETTS INSTITUTE OF TECHNOLOGY) [X] 1,6 * page 6, line 27 - page 7, line 6 * * page 12, line 26 - page 13, line 17 *;
 [X]US5504001  (FOSTER DONALD C) [X] 1,6 * column 3, line 5 - line 55 *;
 [A]WO8809344  (CREATIVE BIOMOLECULES INC) [A] 1,6 * abstract *;
 [A]WO9513091  (INTERNATIONAL TECHNOLOGY MANAGEMENT ASS) [A] 1,6 * abstract *;
 [A]EP0404750  (WASHINGTON UNIVERSITY) [A] 8,12 * abstract *;
 [A]WO9521601  (PROTEIN ENGINEERING CORP.) [A] 8,12 * page 4, line 15 - page 5, line 24 *;
 [A]EP0623676  (AMGEN INC) [A] 1,8,12 * page 1 - page 4 *
 [PX]  - QUAX P H A ET AL, "Inhibition of neointima formation in cultured human saphenous vein segments by an adenovirus expressing an urokinase receptor binding plasmin inhibitor", CIRCULATION, us, (19971021), vol. 96, no. 8-Suppl., page I669, XP002084540 [PX] 1-5,13-15,18,19 * see abstract nr.: 3741 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.